MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$840K
Free Cash flow
-$21,038K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Borrowings on revolving faciliti...
Net income
Depreciation and amortization
Others
Negative Cash Flow Breakdown
Payments on revolving facilities
Accounts receivable
Purchases of property and equipm...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net income
63,775
37,742
44,180
132,611
Distributions from unconsolidated subsidiaries
14,043
10,155
11,723
31,092
Depreciation and amortization
37,666
36,205
34,442
69,656
Provision for expected credit losses
1,098
301
506
1,555
Equity in earnings of unconsolidated subsidiaries
12,011
15,399
12,992
26,130
Loss on extinguishment of debt
-
0
0
-
(gain) loss on sale or disposal of assets
-48
-55
4
43
Stock compensation expense
4,638
4,523
4,255
7,924
Amortization of debt discount and issuance costs
778
783
784
1,569
Deferred income taxes
6,336
20,105
17,895
-7,348
Accounts receivable
86,370
38,698
-83,144
89,631
Other current assets
10,563
-7,911
8,060
-562
Other assets
-5,092
13,864
-1,597
-3,459
Accounts payable
21,196
-18,626
-3,322
21,094
Accrued expenses
-7,866
33,132
1,159
-39,535
Net cash provided by (used in) operating activities
37,860
64,325
175,307
106,835
Proceeds from sale of assets
-
-
-
39
Business combinations, net of cash acquired
-31
7,596
1,601
0
Purchases of property and equipment
58,898
59,100
53,102
117,023
Investment in businesses
-
1,455
-
-
Proceeds from sales and exchanges of assets and sale of business
-
1,259
22,132
-
Proceeds from sales of assets and business
2,212
-
-
-
Net cash used in investing activities
-56,655
-66,892
-32,610
-116,984
Borrowings on revolving facilities
250,000
320,000
200,000
770,000
Payments on revolving facilities
225,000
370,000
300,000
625,000
Proceeds from term loans, net of issuance costs
-
0
0
-
Payments on term loans
2,625
2,625
2,625
5,250
Payment on senior notes, including call premium
-
0
-
-
Proceeds from senior notes, net of issuance costs
-
0
0
-
Borrowings of other debt
19,369
59,696
20,169
21,353
Principal payments on other debt
9,903
8,363
9,274
16,691
Dividends paid to common stockholders
7,751
7,751
7,739
15,945
Repurchases of common stock
0
542
1,970
97,565
Increase (decrease) in overdrafts
2,643
16,751
-16,506
-9,297
Proceeds from issuance of non-controlling interests
5,948
2,940
2,058
10,906
Distributions to and purchases of non-controlling interests
14,726
41,070
19,105
29,707
Purchase of membership interests of concentra group holdings parent
-
0
-
-
Proceeds from concentra initial public offering
-
0
0
-
Cash transferred to concentra at separation
-
0
-
-
Net cash provided by financing activities
17,955
-30,964
-134,992
2,804
Net decrease in cash and cash equivalents
-840
-33,531
7,705
-7,345
Cash and cash equivalents at beginning of period
26,523
60,054
59,694
-
Cash and cash equivalents at end of period
25,683
26,523
60,054
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$63,775K
Borrowings on revolving
facilities
$250,000K
Depreciation and
amortization
$37,666K
Accounts payable
$21,196K
Distributions from
unconsolidated subsidiaries
$14,043K
Deferred income taxes
$6,336K
Other assets
-$5,092K
Stock compensation
expense
$4,638K
Provision for expected
credit losses
$1,098K
Amortization of debt discount
and issuance costs
$778K
(gain) loss on sale or
disposal of assets
-$48K
Borrowings of other debt
$19,369K
Proceeds from issuance of
non-controlling interests
$5,948K
Increase (decrease) in
overdrafts
$2,643K
Net cash provided by
(used in) operating...
$37,860K
Net cash provided by
financing activities
$17,955K
Canceled cashflow
$116,810K
Canceled cashflow
$260,005K
Net decrease in cash
and cash...
-$840K
Canceled cashflow
$55,815K
Proceeds from sales of
assets and business
$2,212K
Business combinations,
net of cash acquired
-$31K
Accounts receivable
$86,370K
Equity in earnings of
unconsolidated subsidiaries
$12,011K
Other current assets
$10,563K
Accrued expenses
-$7,866K
Payments on revolving
facilities
$225,000K
Distributions to and purchases
of...
$14,726K
Principal payments on
other debt
$9,903K
Dividends paid to common
stockholders
$7,751K
Payments on term loans
$2,625K
Net cash used in
investing activities
-$56,655K
Canceled cashflow
$2,243K
Purchases of property and
equipment
$58,898K
Buy us a coffee
SELECT MEDICAL HOLDINGS CORP (SEM)
SELECT MEDICAL HOLDINGS CORP (SEM)